BIOMAT Database Logo BIOMAT Database Logo

Genetic studies of CSF monoamine metabolites. 1984

G Sedvall, and L Iselius, and H Nybäck, and L Oreland, and G Oxenstierna, and S B Ross, and F A Wiesel

UI MeSH Term Description Entries
D008734 Methoxyhydroxyphenylglycol Synthesized from endogenous epinephrine and norepinephrine in vivo. It is found in brain, blood, CSF, and urine, where its concentrations are used to measure catecholamine turnover. Hydroxymethoxyphenylglycol,MHPG,MOPEG,Vanylglycol,4-Hydroxy-3-methoxyphenylethylene Glycol,4-Hydroxy-3-methoxyphenylethyleneglycol,4-Hydroxy-3-methoxyphenylglycol,Methoxyhydroxyphenylglycol, (+)-Isomer,Methoxyhydroxyphenylglycol, (+-)-Isomer,Methoxyhydroxyphenylglycol, (-)-Isomer,4 Hydroxy 3 methoxyphenylethylene Glycol,4 Hydroxy 3 methoxyphenylethyleneglycol,4 Hydroxy 3 methoxyphenylglycol
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D004299 Dopamine beta-Hydroxylase Dopamine beta-Monooxygenase,Dopamine beta Hydroxylase,Dopamine beta Monooxygenase,beta-Hydroxylase, Dopamine,beta-Monooxygenase, Dopamine
D005260 Female Females
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006897 Hydroxyindoleacetic Acid 5-HIAA,5-Hydroxy-3-Indoleacetic Acid,5-Hydroxyindolamine Acetic Acid,5 Hydroxy 3 Indoleacetic Acid,5 Hydroxyindolamine Acetic Acid,Acetic Acid, 5-Hydroxyindolamine,Acid, 5-Hydroxy-3-Indoleacetic,Acid, 5-Hydroxyindolamine Acetic,Acid, Hydroxyindoleacetic
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders

Related Publications

G Sedvall, and L Iselius, and H Nybäck, and L Oreland, and G Oxenstierna, and S B Ross, and F A Wiesel
CSF monoamine metabolites in mania.
April 1983, The American journal of psychiatry,
G Sedvall, and L Iselius, and H Nybäck, and L Oreland, and G Oxenstierna, and S B Ross, and F A Wiesel
CSF monoamine metabolites in melancholia.
March 1984, Acta psychiatrica Scandinavica,
G Sedvall, and L Iselius, and H Nybäck, and L Oreland, and G Oxenstierna, and S B Ross, and F A Wiesel
CSF monoamine metabolites, depression, and suicide.
January 1984, Advances in biochemical psychopharmacology,
G Sedvall, and L Iselius, and H Nybäck, and L Oreland, and G Oxenstierna, and S B Ross, and F A Wiesel
CSF monoamine metabolites in schizophrenic patients.
November 1982, Acta psychiatrica Scandinavica,
G Sedvall, and L Iselius, and H Nybäck, and L Oreland, and G Oxenstierna, and S B Ross, and F A Wiesel
CSF monoamine metabolites in chronic pain.
November 1987, Pain,
G Sedvall, and L Iselius, and H Nybäck, and L Oreland, and G Oxenstierna, and S B Ross, and F A Wiesel
Reproducibility of monoamine metabolites in human CSF.
March 1991, Acta neurologica Scandinavica,
G Sedvall, and L Iselius, and H Nybäck, and L Oreland, and G Oxenstierna, and S B Ross, and F A Wiesel
CSF monoamine metabolites in depression and schizophrenia.
February 1980, The American journal of psychiatry,
G Sedvall, and L Iselius, and H Nybäck, and L Oreland, and G Oxenstierna, and S B Ross, and F A Wiesel
Monoamine metabolites in CSF and suicidal behavior.
June 1981, Archives of general psychiatry,
G Sedvall, and L Iselius, and H Nybäck, and L Oreland, and G Oxenstierna, and S B Ross, and F A Wiesel
CSF monoamine metabolites in old age dementias.
January 1992, Molecular and chemical neuropathology,
G Sedvall, and L Iselius, and H Nybäck, and L Oreland, and G Oxenstierna, and S B Ross, and F A Wiesel
Monoamine metabolites in the CSF of epileptic patients.
August 1979, Neurology,
Copied contents to your clipboard!